Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line

Biochemical and Biophysical Research Communications
Naoki OguraTakaji Wakita

Abstract

Chronic hepatitis B virus (HBV) infection is currently a major public health burden. Therefore, there is an urgent need for the development of novel antiviral inhibitors. The stable HBV-producing cell lines of genotype D are widely used to investigate the HBV life cycle and to evaluate antiviral agents. However, stable HBV-producing cell lines of different genotypes do not exist. To construct more convenient and efficient novel cell systems, stable cell lines of genotypes A, B, and C were established using a full-length HBV genome sequence isolated from chronic HBV patients in human hepatoma HepG2 cells. Novel HBV clones were identified and stable HBV-producing cell lines derived from these clones were constructed. HBV replication activities demonstrated time-dependent expression, and the novel cell lines were susceptible to several antiviral inhibitors with no cytotoxicity. Furthermore, infectious viruses were produced from these cell lines. In conclusion, we have established novel stable HBV-producing cell line systems of genotypes A, B, and C. These systems can provide valuable tools for screening antiviral agents and analyzing viral phenotypes in vitro.

References

Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M A SellsG Acs
May 23, 2003·Antimicrobial Agents and Chemotherapy·Kathie-Anne WaltersLorne Tyrrell
Oct 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yong-Yuan ZhangJesse Summers
Dec 23, 2003·Intervirology·Yuzo Miyakawa, Masashi Mizokami
Feb 22, 2005·Journal of Viral Hepatitis·S Schaefer
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Masataka TsugeKatsutoshi Yoshizato
Jul 28, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Atsushi OzasaMasashi Mizokami
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Masaya SugiyamaMasashi Mizokami
Sep 19, 2007·Antimicrobial Agents and Chemotherapy·Anne Marie DoughertyAndrea Cuconati
Nov 6, 2007·Clinics in Liver Disease·Timothy M BlockJu-Tao Guo
Apr 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T Jake Liang
Sep 10, 2009·Gastroenterology·Fabien Zoulim, Stephen Locarnini
Sep 28, 2010·Journal of Medical Virology·Pok YeungMan-Fung Yuen
Jan 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Fabien Zoulim, Stephen Locarnini
Jul 31, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kiyoaki ItoUNKNOWN Japanese AHB Study Group
Dec 18, 2013·Biochemical and Biophysical Research Communications·Masashi IwamotoTakaji Wakita
Jul 19, 2014·Intervirology·Anna Kramvis
Aug 26, 2014·Biochemical and Biophysical Research Communications·Naoki OguraTakaji Wakita
Apr 8, 2015·World Journal of Hepatology·Catherine Mn CroaghSally J Bell
Oct 31, 2015·The Journal of Infection·Eisuke MurakamiKazuaki Chayama
Sep 28, 2016·World Journal of Gastroenterology : WJG·Bing-Fang Chen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.